Bir sonraki

Otomatik oynatma

First-Line Treatment of HER2-Positive Metastatic Breast Cancer

2 Görünümler • 07/03/23
Pay
gömmek
administrator
administrator
Aboneler
0

Panelists discuss the combination of trastuzumab, pertuzumab, and docetaxel as frontline treatment for patients with HER2-positive metastatic breast cancer.

To view more from this discussion, visit http://www.onclive.com/peer-exchange/mbc-community

Daha fazla göster
0 Yorumlar sort Göre sırala
Facebook Yorumları

Bir sonraki

Otomatik oynatma